.
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.
.
"the drug must be administered at the right time point during development," he said.
.
.
.
family slam health trust after pensioner's 'undignified' death
.